ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00336687
Recruitment Status : Completed
First Posted : June 14, 2006
Last Update Posted : March 29, 2010
Sponsor:
Collaborators:
Moulins Hospital
Centre Hospitalier Universitaire de Saint Etienne
LA ROCHE SUR YON HOSPITAL
Information provided by:
University Hospital, Clermont-Ferrand

Brief Summary:
About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares.

Condition or disease
Thrombopenia

Detailed Description:
About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares.

Study Type : Observational
Estimated Enrollment : 322 participants
Time Perspective: Prospective
Official Title: Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.
Study Start Date : July 2005
Actual Study Completion Date : November 2006



Primary Outcome Measures :
  1. Epidemiology of Thrombopenia and its consequences. [ Time Frame: in reanimation ]

Secondary Outcome Measures :
  1. The impact of cost and mortality of Thrombopenia in reanimation. [ Time Frame: in reanimation ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients of Reanimation
Criteria

Inclusion Criteria:

  • Thrombopenia in reanimation

Exclusion Criteria:

  • Pregnancy
  • Contraindication of myelogram

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00336687


Locations
France
Clermont-Ferrand University Hospital
Clermont-Ferrand, Auvergne, France, 63000
Sponsors and Collaborators
University Hospital, Clermont-Ferrand
Moulins Hospital
Centre Hospitalier Universitaire de Saint Etienne
LA ROCHE SUR YON HOSPITAL
Investigators
Study Director: Fabrice Thiolliere, Dr University Hospital, Clermont-Ferrand

Responsible Party: Fabrice Thiollière, CHU Clermont-Ferrand
ClinicalTrials.gov Identifier: NCT00336687     History of Changes
Other Study ID Numbers: CHU63-0013
First Posted: June 14, 2006    Key Record Dates
Last Update Posted: March 29, 2010
Last Verified: March 2010

Keywords provided by University Hospital, Clermont-Ferrand:
Thrombopenia
Reanimation
Thrombopenia in reanimation

Additional relevant MeSH terms:
Thrombocytopenia
Blood Platelet Disorders
Hematologic Diseases